November 18th 2024
More than half of US adults—approximately 137 million—are candidates for semaglutide based on diabetes, weight management, or cardiovascular prevention indications.
November 16th 2024
Dave Dixon from Virginia Commonwealth University: No Magic Pill in Treatment of Obesity
Despite recently approved medications showing improvement over previously used diet pills and other treatments there is still no medicinal cure for obesity and the best hope for patients in many cases is lifestyle changes.
Dave Dixon from Virginia Commonwealth University: Anti-Obesity Agents Provide Some Hope for Patients
The US Food and Drug Administration recently approved some new tools in the fight against obesity. While they provide some help for patients looking to lose weight there are also side effects which doctors and patients patients to consider.
Do Depression, Lack of Vitamin D, Increase MS Risk?
April 11th 2016Multiple sclerosis (MS) patients at diagnosis have a higher rate of comorbid conditions -- including depression and diabetes Canadian researchers found.The intriguing question is whether such conditions put people at higher risk of MS.